Neurovalens, a global leader in non-invasive neuro-technology, has appointed Kate Willis to oversee the sales of the belfast firms prescribed medical devices in the US
Melanoma cancer kills 57,000 people each year worldwide, and costs health services billions. With the World Health Organisation predicting new cases to rise to more than half a million a year by 2040, an Irish start-up, Klas Therapeutics, has discovered a new more affordable treatment